Boston Scientific Corp
Boston Scientific (BSX) is showcasing notable strength with a current price of $62.56, reflecting a year-over-year EPS growth of 55.57% and impressive revenue growth of 19.88%. The stock has a market cap of $92.98B, and with a solid analyst consensus of 13 Strong Buy ratings, investors are positioned for potential upside as it remains well below its 52-week high of $109.5.
I recommend investors consider buying BSX for potential long-term gains, given its strong growth metrics and favorable analyst outlook.
Tired of AI and Oil? Buy the Robot.
2026-04-08
Is It Time To Revisit Boston Scientific (BSX) After This Year’s Sharp Share Price Pullback
2026-04-08
Boston Scientific (BSX) Stock Sinks As Market Gains: Here's Why
2026-04-07
Leerink Reiterates Outperform on Boston Scientific (BSX) After CHAMPION-AF Readout
2026-04-07